Remission of type 2 diabetes in a young, hypogonadal man under long-term testosterone therapy: A case report

<p>Background: The increasing prevalence of obesity, in particular in young patients, represents a growing clinical and health-care cost problem. Young adulthood obesity strongly increases the risk of type 2 diabetes (T2DM), hypertension, myocardial infarction, stroke or venous thromboembolism...

Full description

Saved in:
Bibliographic Details
Main Authors: George Mskhalaya (Author), Yulia Tishova (Author), Anas Alfaradzh (Author), Svetlana Kalinchenko (Author)
Format: Book
Published: Global Journal of Obesity, Diabetes and Metabolic Syndrome - Peertechz Publications, 2020-06-05.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-8583_000043
042 |a dc 
100 1 0 |a George Mskhalaya  |e author 
700 1 0 |a  Yulia Tishova  |e author 
700 1 0 |a  Anas Alfaradzh  |e author 
700 1 0 |a Svetlana Kalinchenko  |e author 
245 0 0 |a Remission of type 2 diabetes in a young, hypogonadal man under long-term testosterone therapy: A case report 
260 |b Global Journal of Obesity, Diabetes and Metabolic Syndrome - Peertechz Publications,   |c 2020-06-05. 
520 |a <p>Background: The increasing prevalence of obesity, in particular in young patients, represents a growing clinical and health-care cost problem. Young adulthood obesity strongly increases the risk of type 2 diabetes (T2DM), hypertension, myocardial infarction, stroke or venous thromboembolism. Young obese T2DM men have a high prevalence of low testosterone concentrations indicating eugonadotropic hypogonadism. An existing but undetected testosterone deficiency will substantially hamper weight loss or render it impossible. In such cases, returning the testosterone level to normal range is therefore the necessary pre-condition to fight obesity and thus the related comorbidities.</p><p>Case presentation: A 20-year-old man with grade III obesity complained of fatigue, dry mouth, and erectile dysfunction (ED). Medical examination revealed uncontrolled T2DM, pronounced dyslipidemia, severe vitamin D deficiency, and a remarkably low testosterone level. Medication with metformin   and vitamin D was initiated and testosterone therapy (TTh) was started. Under TTh, the patient continuously lost weight, and his blood sugar and lipid profile progressively normalized. Finally, a complete remission of T2DM was reached and all baseline complaints including ED were fully gone. Even after TTh was stopped, all respective values remained in the normal range. </p><p>Conclusions: We conclude that TTh worked as a necessary stimulus along with standard therapy for consequential facilitation of weight reduction and associated recovery of the body's own production of testosterone in particular in terms of a complete remission of T2DM.</p> 
540 |a Copyright © George Mskhalaya et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-8583.000043  |z Connect to this object online.